| Financial Year |
March 31 2023 |
| Monetary Funds |
1,840,304,024.98 |
| Held-for-trading Financial Assets |
131,630,368.45 |
| Notes Receivable |
144,355,170.86 |
| Accounts Receivable |
5,268,712,774.46 |
| Advances to Suppliers |
246,081,234.99 |
| Other Receivables |
370,169,351.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
630,403,583.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
471,411,480.55 |
| Total Current Assets |
9,816,734,587.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,876,697.20 |
| Investment Properties |
100,301,053.23 |
| Fixed Assetes |
1,944,357,241.76 |
| Under-construction Projects |
166,241,348.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
291,379,359.78 |
| R&D expenses |
-- |
| Goodwill |
100,956,607.71 |
| Long-Term Deferred and Prepaid Expenses |
2,124,854.86 |
| Deferred Income Tax Assets |
231,195,950.49 |
| Other Non-Current Assets |
117,232,923.26 |
| Sub-Total of Non-Current Assets |
3,176,538,443.88 |
| Total Assets |
12,993,273,031.02 |
| Short-Term Loans |
1,188,673,133.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,741,929,820.39 |
| Accounts Payable |
1,979,683,686.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
84,965,676.19 |
| Taxes Payable |
73,690,239.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
252,528,959.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
577,869,788.68 |
| Other Current Liabilities |
27,241,132.56 |
| Sub-Total of Current Liabilities |
6,325,990,880.05 |
| Long-term Loans |
840,306,601.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,408,026.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
100,515,838.71 |
| Deferred Income Tax Liabilities |
14,827,814.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,044,244,172.29 |
| Total Liabilities |
7,370,235,052.34 |
| Paid-In Capital(Or Share Stock) |
1,180,878,627.00 |
| Capital Surplus |
2,082,004,265.92 |
| Surplus Reserve |
191,482,550.53 |
| LESS:Treasury Stock |
196,604,069.23 |
| Undistributed Profits |
2,376,418,935.43 |
| Minority Stockholder's Interest |
802,095.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,622,235,883.09 |
| Owner's Equity（Stockholder's Equity） |
5,623,037,978.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,993,273,031.02 |
